FY2024 Earnings Estimate for Tilray Inc (NASDAQ:TLRY) Issued By Roth Capital

Tilray Inc (NASDAQ:TLRY) – Stock analysts at Roth Capital reduced their FY2024 EPS estimates for shares of Tilray in a research note issued on Wednesday, April 10th. Roth Capital analyst W. Kirk now expects that the company will earn ($0.34) per share for the year, down from their previous forecast of ($0.29). The consensus estimate for Tilray’s current full-year earnings is ($0.28) per share. Roth Capital also issued estimates for Tilray’s Q4 2024 earnings at ($0.04) EPS, Q1 2025 earnings at ($0.08) EPS, Q2 2025 earnings at ($0.08) EPS, Q3 2025 earnings at ($0.08) EPS, Q4 2025 earnings at ($0.06) EPS and FY2025 earnings at ($0.30) EPS.

TLRY has been the topic of several other research reports. CIBC reduced their price target on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 10th. Alliance Global Partners boosted their price objective on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a report on Friday, April 5th. Finally, Canaccord Genuity Group dropped their price objective on Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a report on Wednesday, April 10th.

Tilray Stock Down 2.2 %

Shares of NASDAQ TLRY opened at $1.78 on Monday. The firm’s 50-day simple moving average is $1.97 and its 200 day simple moving average is $1.97. The company has a market cap of $1.32 billion, a price-to-earnings ratio of -4.05 and a beta of 2.36. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11. Tilray has a 12-month low of $1.50 and a 12-month high of $3.40.

Institutional Trading of Tilray

Institutional investors and hedge funds have recently modified their holdings of the stock. Macquarie Group Ltd. increased its stake in shares of Tilray by 188.8% in the 2nd quarter. Macquarie Group Ltd. now owns 8,540 shares of the company’s stock valued at $27,000 after acquiring an additional 5,583 shares during the last quarter. Cetera Advisor Networks LLC acquired a new position in shares of Tilray in the 1st quarter valued at approximately $82,000. Clear Street Markets LLC acquired a new position in shares of Tilray in the 3rd quarter valued at approximately $25,000. Kingsview Wealth Management LLC acquired a new position in shares of Tilray in the 2nd quarter valued at approximately $33,000. Finally, Squarepoint Ops LLC acquired a new position in shares of Tilray in the 4th quarter valued at approximately $30,000. 9.35% of the stock is owned by institutional investors.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.